Diagnostic value of copeptin in febrile seizures

Diagnostic value of copeptin in febrile seizures - EpiCop

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006251

Enrollment

350

Registered

2014-06-23

Start date

2014-06-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral seizures, febrile infection (e. g. with focus in the airways or in the gastrointestinal tract) R56.0 B99 R56.8

Interventions

Group 1: Identification of the diagnostic value of copeptin and von Willebrand factor, von Willebrand collagen binding activity and von Willebrand multimers in children with cerebral seizures includin

Eligibility

Sex/Gender

All

Age

No minimum to 6 Years

Inclusion criteria

Inclusion criteria: 1) Children 38°C measured at the emergency unit.

Exclusion criteria

Exclusion criteria: No medically indicated blood tests at the emergency unit.

Design outcomes

Primary

Measure	Time frame
Copeptin serum level in children with febrile seizures presenting at our emergency ward compared to children with fever but without seizures	—

Secondary

Measure	Time frame
1) Copeptin serum level after febrile seizures compared to cerebral seizures without fever 2) Blood pH in all patients compared to type of seizures and value of copeptin 3) Level of von Willebrand-factor and von Willebrand-multimers as well as von Willebrand collagen binding activity in children with febrile seizures compared to children with fever but without seizuers	—

Countries

Germany, Switzerland

Contacts

Public ContactAstrid Pechmann

Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg

astrid.pechmann@uniklinik-freiburg.de+49 761 270-43000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026